Navigation Links
China Medical Technologies Reports Second Fiscal Quarter Financial Results
Date:11/17/2010

>

41,399Convertible notes

2,777,086

2,556,014

2,528,848

377,976Deferred income taxes

67,134

72,518

78,408

11,720Total liabilities

3,105,373

2,895,222

2,884,241

431,095Shareholders' equityOrdinary shares US$0.1 par value:

500,000,000 authorized; 322,680,001 issued and outstanding as of March 31, 2010, June 30, 2010 and September 30, 2010

258,840

258,840

258,840

38,688Additional paid-in capital

808,221

820,778

830,016

124,058Treasury stock

(45,143)

(47,108)

(47,108)

(7,041)Accumulated other comprehensive loss

(70,556)

(70,731)

(74,412)

(11,122)Retained earnings

852,334

886,012

883,076

131,990Total shareholders' equity

1,803,696

1,847,791

1,850,412

276,573Total liabilities and shareholders' equity

4,909,069

4,743,013

4,734,653

707,668China Medical Technologies, Inc.Unaudited Condensed Consolidated Statements of IncomeFor the Three Months EndedSeptember 30, 2009June 30, 2010September 30, 2010RMBRMBRMBUS$   As adjusted (4)(in thousands except for per ADS information)Revenues, net (1)

166,066

186,170

201,834

30,167Cost of revenues (2)

(57,517)

(61,354)

(90,477)

(13,523)Gross profit

108,549

124,816

111,357

16,644Operating expensesResearch and development (2)

(9,500)

(10,632)

(10,877)

(1,625)Sales and marketing (2)

(17,432)

(18,266)

(21,473)

(3,209)General and administrative (2)

(45,130)

(25,149)

(25,048)

(3,744) Amortization of SPR intangible assets

(27,357)

(27,329)

-

-Total operating expenses

(99,419)

(81,376)


'/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)...  PANTHERx Specialty Pharmacy announced today that it ... a Washington, DC -based health ... the health care industry. Logo - ... accreditation process demonstrates a commitment to quality services ... processes through benchmarking organizations against nationally recognized standards. ...
(Date:9/2/2014)... Actavis plc (NYSE: ACT ) ... (FDA) has accepted for filing Actavis, New Drug Application ... of diarrhea and abdominal pain in men and women ... for eluxadoline has been granted priority review status by ... "The NDA filing of eluxadoline marks an ...
(Date:9/2/2014)... , Sept. 2, 2014  Boston Scientific Corporation ... previously announced agreement to purchase the Interventional business ... of Boston Scientific to offer physicians and healthcare ... treat challenging vascular conditions. The addition ... innovative technologies supports the Boston Scientific strategy to ...
Breaking Medicine Technology:PANTHERx Specialty Pharmacy Applying for URAC Specialty Pharmacy Accreditation 2Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline 2Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline 3Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline 4Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 2Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 3Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 4Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 5
(Date:9/2/2014)... 02, 2014 With recent expansions to their ... to create a consistent look or specific ambiance that tells ... floor you walk on and the chair you sit in, ... wood designs. , “We’re excited to offer a more ... It saves time, adds consistency, and let’s not forget celebrates ...
(Date:9/2/2014)... Cleveland, Ohio (PRWEB) September 02, 2014 ... Cellulon® Polyurethane technology to reduce discomfort and fatigue by ... flooring. Using an eco-friendly, renewable bio-foam core, these anti-fatigue ... in the USA. According to a study by the ... showing a significant difference in reducing spinal compression and ...
(Date:9/2/2014)... white pill may help scientists learn why patients with ... even if their lungs are relatively healthy. , ... Revatio to treat pulmonary hypertension and Viagra for erectile ... antioxidants will help them identify the root of the ... patients. , "We want to understand why these ...
(Date:9/2/2014)... of opioid-involved overdoses has become an increasing concern to ... the New York City Department of Health and Mental ... 2011 was nearly triple the number of such deaths ... to a dramatic rise in nonmedical prescription opioid (PO) ... in heroin use among youth who transitioned from POs ...
(Date:9/2/2014)... 2014In a new guideline, the Society for Maternal-Fetal Medicine ... in pregnancy. , "There is no evidence that ... of Delaware Center for Maternal and Fetal Medicine and ... is evidence that bed rest can be harmful for ... five women are placed on bed rest during their ...
Breaking Medicine News(10 mins):Health News:Pioneer Millworks Now Offering Products Beyond Reclaimed Wood Flooring 2Health News:New Eco-Pro Premium Anti-fatigue Mats from Martinson-Nicholls Prevent Fatigue and Discomfort for Standing Workers 2Health News:Drug that improves blood flow may help find cause of exercise intolerance in cystic fibrosis 2Health News:Drug that improves blood flow may help find cause of exercise intolerance in cystic fibrosis 3Health News:Drug that improves blood flow may help find cause of exercise intolerance in cystic fibrosis 4Health News:NYC teens and young adults who abuse prescription at high risk for overdose 2Health News:NYC teens and young adults who abuse prescription at high risk for overdose 3Health News:SMFM releases paper on activity restriction in pregnancy 2
... saves a life. Saturday, April 25 is World Malaria Day. , ... ... teaming up with the United Nations Foundation and its Nothing But Nets ... his New Look Foundation, Raymond and the UN Foundation will provide opportunities ...
... | About 400 cancer therapy specialists from 100 countries ... week in Vienna at an IAEA event to discuss modern ... Conference on Advances in Radiation Oncology (ICARO) will start on ... the Vienna International Center. , All sessions of the ...
... Medical Technologies, Inc. (Nasdaq: PMTI ), a leading ... hold its quarterly conference call of its 2009 first quarter ... Eastern Time. If you would like to participate, please call ... The telephone replay will be available one hour after the ...
... Addicts, even those who have been abstinent for long ... memories of prior drug use. For example, exposure to ... a contextual memory can increase their craving for the ... study in the April 15th issue of Biological Psychiatry ...
... CINCINNATI, April 23 Kendle (Nasdaq: KNDL ... quarter 2009 financial results after the market closes on ... telephone conference call and simultaneous webcast on Thursday, May ... answer session will follow.(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO ...
... PALO ALTO, Calif., April 23 Percutaneous Systems, Inc. ... Accordion CoAx(TM) Stone Control Device, the newest member ... tools, at the upcoming annual meeting of the American ... Chicago, Illinois.The Accordion CoAx Stone Control Device is an ...
Cached Medicine News:Health News:IAEA conference to focus on new techniques in cancer treatment 2Health News:Palomar Medical Technologies to Host First Quarter 2009 Financial Results Conference Call and Webcast on April 30, 2009 2Health News:Treating addiction by eliminating drug-associated memories 2Health News:Kendle Announces First Quarter 2009 Earnings Conference Call and Webcast 2Health News:PercSys Introduces Accordion CoAx(TM) Stone Control Device for Facilitating Percutaneous Kidney Stone Treatments 2Health News:PercSys Introduces Accordion CoAx(TM) Stone Control Device for Facilitating Percutaneous Kidney Stone Treatments 3
... DTX Series Multimode Detectors provide unmatched ... of application and automation needs. Capable ... measurements on the same instrument, the ... instruments or can be integrated seamlessly ...
... PCR, cDNA and Oligonucleotides The Tecan ... a variety applications that are quantified by Fluorescence, ... handle assays in Microplate formats from 6 ... Cuvettes Independent whether you have to ...
... Designed for Ultra High Throughput Screening ... assay detection performance. Allows for smooth ... assay development by sharing all the ... HT, fluorescence intensity, fluorescence polarization, time-resolved ...
... system used to detect and quantitate contaminants, ... cell protein, bovine contaminants (e.g., BSA, IgG, ... any unique protein that can be bound ... and plasmid copy number. The system reduces ...
Medicine Products: